If you're enrolled in the Saving on a Valuable Education income-driven repayment plan, experts say to prepare for changes.

The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.

Key interim two-year follow-up data being presented at VESS includes: 78% of subjects (n=25/32) maintained a clinically meaningful benefit, defined as an improvement of 3 or more points in the ...

We can all do more to be more conscious about what we buy, and where we buy it from. Buying less will save you money, reduce waste and improve your environmental footprint. Living a less consumerist ...

The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.